Intracoronary administration of metabolic agents in the treatment of acute coronary syndrome
The article presents the new possibilities of preventing the onset of irreversible myocardial damage during ischemia and effective approaches undertaken in the early reperfusion period (per - and postconditioning of the myocardium) through coronary the introduction of cardioprotective drugs. Practit...
Main Authors: | A. A. Spasski, A. A. Mikhaylov, A. Yu. Kharitonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-05-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/92 |
Similar Items
-
Logistic ways of handling domestic medicines of derivatives etilmetilgidroksipiridina succinate at the regional pharmaceutical market
by: I. I. Pavlyuchenko, et al.
Published: (2015-08-01) -
EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01) -
EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01) -
The Effect of Ethylmethylhydroxypyridine Succinate on the Dynamics of Cerebral Blood Flow Patterns in Patients with Acute Concomitant Traumatic Brain Injury
by: E. A. Abramova, et al.
Published: (2017-06-01) -
Cerebral Circulation and Metabolism of Patients with Cerebral Injury
by: Ekaterina A. Abramova, et al.
Published: (2018-03-01)